Interestingly, in two patients with 100% and 75% RANK+ CMCs, immunofluorescence staining of metastases, which had been removed one month prior to blood collection for CTC analysis, showed only a small fraction (2%) of RANK+ cells within the tumor. This evidence concerns the gene TNFRSF11A and neoplasm.